Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South Africa
Author(s) -
Brian Williams,
Salim S. Abdool Karim,
Quarraisha Abdool Karim,
Eleanor Gouws
Publication year - 2011
Publication title -
jaids journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3182253c19
Subject(s) - microbicide , medicine , tenofovir , environmental health , population , epidemiology , pre exposure prophylaxis , human immunodeficiency virus (hiv) , transmission (telecommunications) , demography , microbicides for sexually transmitted diseases , sexual transmission , incidence (geometry) , men who have sex with men , virology , health services , syphilis , physics , optics , sociology , electrical engineering , engineering
Tenofovir gel, an antiretroviral-based vaginal microbicide, reduced HIV acquisition by 39% in women in a recent randomized controlled clinical trial in South Africa.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom